Similar neurobehavioral outcome after valve or coronary artery operations despite differing carotid embolic counts  by Neville, Michael J. et al.
Objectives: The interrelationships among coronary and valvular operations,
microemboli, and neurobehavioral outcome are unclear. We hypothesized that
adult patients undergoing cardiac valve operations would have more total
emboli delivered to the brain than patients undergoing coronary artery bypass
grafting and that this would associate with worse neurobehavioral outcomes.
Methods: One hundred ninety-three patients undergoing coronary artery
bypass grafting and 73 patients undergoing cardiac valve operations were
compared. Patients received neurologic, neuro-ophthalmologic, and 11 stan-
dardized neurobehavioral tests preoperatively and 5 to 7 days, 1 month, and
6 months postoperatively. Left common carotid Doppler ultrasonographic
embolus detection was performed intraoperatively. Repeated measures and
logistic regression analyses of outcome were performed.
Results: Patients undergoing either coronary or valve operations were well
matched by age (61 ± 10 and 59 ± 12 years, respectively), but a significant-
ly greater fraction of patients undergoing valve operations were female, dia-
betic, or had undergone previous cardiac operations. Neurobehavioral scores
of patients undergoing either coronary artery bypass grafting or cardiac valve
operations did not differ significantly at any time. Total embolus counts dif-
fered significantly: the median was 105 during coronary artery bypass graft-
ing and 479 during cardiac valve operations (geometric means of 104 and
412, respectively; P = .0001). Significantly more emboli were detected in the
patients undergoing cardiac valve operations after removal of the left ven-
tricular vent and after separation from cardiopulmonary bypass, but compa-
rable numbers of emboli were seen in the 2 groups before cardiopulmonary
bypass. In both groups decreased neurobehavioral performance was appar-
ent at 5 to 7 days, with improvement at 1 and 6 months. Increasing numbers
of carotid emboli significantly associated with worse performance on the let-
ter cancellation test. There were no significant differences between patients
undergoing valve and coronary operations in neurobehavioral outcomes,
strokes, transient ischemic attacks, or deaths.
Conclusions: The significantly greater number of emboli in the group of
patients undergoing cardiac valve operations is likely the result of the
entrainment of intracardiac air. The greater numbers of emboli during car-
diac valve operations do not appear associated with a commensurately
greater risk of adverse neurologic or neurobehavioral outcome. (J Thorac
Cardiovasc Surg 2001;121:125-36)
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Neurologic and neurobehavioral outcomes have beenintensively studied in patients undergoing coronary
artery bypass grafting (CABG) and cardiac valve opera-
tions. In the early years of CABG operations, the proce-
dure was performed most often on middle-aged patients
with relatively few comorbid conditions. More recently,
with improvements in medical management of coronary
artery disease and with wide application of percutaneous
transarterial coronary interventions, the patient popula-
tion presenting for CABG is older and sicker than in ear-
lier times. During the same time period, patients with
cardiac valve disease were being referred earlier in the
natural history of their disease because of improvements
in surgical-anesthesia techniques and prosthetic materi-
als. The interrelationships among aging, coronary and
valvular operations, gaseous and particulate cerebral
microemboli, and neurobehavioral outcomes are
unclear. We hypothesize that adult patients undergoing
cardiac valve operations would have a greater number of
emboli delivered to the brain than patients undergoing
coronary artery bypass graft operations and that this
greater embolic load would be associated with a worse
neurobehavioral outcome.1 We tested this hypothesis by
using control data gathered during 2 randomized clinical
trials evaluating neuroprotection in cardiac valve opera-
tions and CABG. The primary outcome results of these
2 trials have been reported.1-3
Methods and materials
Our 2 clinical trial protocols were reviewed and approved
by our institutional review board. Each patient gave his or her
consent to participate. Three hundred eighty-one patients
scheduled for elective CABG during 1991 through 1996 and
147 patients scheduled for elective cardiac valve operations
from 1992 to 1995 were enrolled in 2 separate neuroprotec-
tion trials. The control group of the CABG study (193
patients) was then compared with the control group of the
cardiac vale operation study (74 patients) with respect to neu-
robehavioral outcome. All patients undergoing cardiac valve
operations underwent operations on the aortic valve, mitral
valve, or both, with or without concurrent CABG. Exclusion
criteria for the 2 studies are provided in Table I.
Each patient underwent a standard battery of neurobehav-
ioral tests, including tests of memory function (Rey Auditory
Verbal Learning and Nonverbal Memory Tests) and tests of
attention, concentration and psychomotor performance (Trail
Making Forms A and B, Grooved Pegboard in dominant and
nondominant hands, Finger Tapping in dominant and non-
dominant hands, Letter Cancellation, Digit-Symbol, and
Visual Reaction Time tests).4 The neurobehavioral tests were
performed once preoperatively and on 3 occasions postoper-
atively. Because psychomotor ability is reversibly diminished
by pain, fatigue, and anesthesia, all of which inevitably
accompany operations, the first postoperative evaluation was
delayed to between postoperative days 5 and 7. Testing was
repeated at 1 and 6 months after operations. Parallel forms of
the Rey Auditory Verbal Learning, the Nonverbal Memory,
Digit-Symbol, Wechsler Memory, Letter Cancellation, and
Visual Reaction Time tests were used to minimize learning
effects. There are no parallel forms for the other tests. Brief
neurologic and neuro-ophthalmologic examinations (consist-
ing of assessment of cranial nerves, deep tendon reflexes,
motor and sensory function, cerebellar function, visual acu-
ity, visual field deficits, and a funduscopic examination for
retinal emboli, optic nerve infarction, retinal hemorrhage, and
papilledema) were performed on the same schedule. These
examinations were recorded in part by using the National
Institutes of Health Stroke Scale, in the use of which all test
examiners were certified.
All patients were anesthetized with fentanyl (up to 100
µg/kg) and midazolam (up to 0.3 mg/kg) and were paralyzed
with pancuronium (up to 0.2 mg/kg), metocurine (up to 0.4
mg/kg), or both. Some patients received enflurane as needed
as a supplemental anesthetic. No other volatile anesthetics
were permitted. Thiopental, ketamine, propofol, and nitrous
oxide were not used. The operations were accomplished dur-
ing moderate hypothermia (28°C) and cardiopulmonary
bypass (CPB). During CABG operations, the distal anasto-
moses were accomplished with the aorta crossclamped,
whereas proximal anastomoses were sewn after application
of a side-biting partial occlusion clamp to the proximal aorta.
Cardiac valve operations were accomplished during aortic
crossclamping.
One hundred fifty (78%) of the patients undergoing CABG
and 38 (51%) of the patients undergoing cardiac valve oper-
ations underwent continuous Doppler examination of the left
common carotid artery during their operations for detection
of carotid arterial emboli. The 5-MHz continuous wave
Doppler probe (Carolina Medical Electronics, King, NC) was
applied after induction of anesthesia. The data were individ-
ually recorded on VHS video tapes for post hoc analysis.
Research personnel documented the precise times that spe-
cific surgical maneuvers took place and marked the tapes
accordingly.5 Atherosclerosis of the proximal aorta was
assessed by palpation and graded using a standard scale.
Epiaortic scanning was not used.
As part of the clinical neuroprotection trial, patients under-
going CABG were randomly assigned to have intraoperative
blood glucose controlled with an insulin infusion or a place-
bo infusion. The patients undergoing cardiac valve operations
were enrolled in a separate clinical neuroprotection trial in
which they were randomly assigned to receive either
nimodipine (total of 1.75 mg/kg over 4 oral doses) or place-
bo perioperatively. The present study used only the control
patients from these 2 clinical neuroprotection trials.
Patients who died perioperatively lacked postoperative neu-
robehavioral, neurologic, and neuro-ophthalmologic assess-
ment and were not included in neurobehavioral analyses. Data
were included from patients with perioperative and postoper-
ative strokes when neurobehavioral test scores were available.
Demographic differences between the patients undergoing
CABG and cardiac valve operations were compared by using
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the t test or exact χ2 test as appropriate. If log-transformed
data were analyzed, we report geometric means (the geomet-
ric mean is the antilog of the mean of the log-transformed
data) in the text, tables, and figures. Differences between the
patients undergoing cardiac valve operations and those under-
going CABG in their neurobehavioral test scores (as percent-
age change from baseline) were compared over the examina-
tions at 5 to 7 days, 1 month, and 6 months by using mixed
models repeated measures. Covariates for cardiac valve or
CABG operations, sex, age (fit as linear and quadratic terms),
surgeon, and number of emboli were included in the repeated-
measures analyses. Interactions between number of emboli
and examination date (eg, 5-7 days vs 1 month), number of
emboli and type of operation, and type of operation and exam-
ination date were also included. A neurobehavioral deficit was
defined as a decline of 20% or more from the baseline value
that each subject scored preoperatively on any neurobehav-
ioral test. Incidence of deficits was compared between patients
undergoing CABG and cardiac valve operations at each exam-
ination date by using logistic regression. Explanatory factors
for type of operation, sex, age class (≤60 vs >60 years), extent
of aortic atherosclerosis (assessed by palpation), and number
of emboli were included in the models. Differences between
the patients undergoing CABG and cardiac valve operations
in total emboli counts were compared by using log-trans-
formed t tests. In addition to the total counts, embolus counts
were recorded within 2 minutes of predefined surgical maneu-
vers. The large number of zero embolus values (often for over
50% of the patients undergoing CABG) made t tests or log-
transformed t tests impractical for analyzing the embolus
counts during defined surgical maneuvers. Large differences
between the shapes of the CABG and cardiac valve operation
emboli distributions invalidated the Wilcoxon rank-sum test.
Thus the distributional assumption-free Kolmogorov-Smirnov
test was used to test for overall distributional differences in the
embolus counts during the defined surgical maneuvers.
Spearman rank correlation was used to test for an association
between age and total number of emboli. All statistical analy-
ses were accomplished by using the SAS (version 8.0) pro-
gram (SAS Institute, Cary, NC).
Results
The demographic characteristics of the patients
undergoing either CABG or cardiac valve operations
are provided in Table II. As expected, female patients
formed a much smaller fraction of the CABG (n = 35
[18%]) than cardiac valve operation (n = 41 [56%])
population, both because of the lower incidence of
coronary artery disease in female as opposed to male
patients and as a result of our having excluded insulin-
dependent diabetic subjects from the CABG study pop-
ulation. The 2 groups were well matched by age. The
patients undergoing cardiac valve operations had a
much higher incidence of transient ischemic attacks
(TIAs) and atrial fibrillation and were less likely to be
undergoing their first cardiac operation. The duration
of CPB was significantly longer in cardiac valve oper-
ations than CABG (medians, 145 vs 116 minutes; geo-
metric means, 142 vs 116 minutes, respectively; 
P < .0001) as was the duration of aortic clamping
(medians, 93 vs 52 minutes; arithmetic means, 95 vs 57
minutes, respectively; P < .0001).
There were differences between the groups in
myocardial protection and venting techniques. Eighty-
two percent of patients undergoing cardiac valve oper-
ations and 80% of patients undergoing CABG received
intermittent blood cardioplegia, 1% of patients under-
going CABG (and no patients undergoing cardiac valve
operations) received no cardioplegia, and the remain-
ing patients received intermittent crystalloid cardiople-
gia. These differences were not statistically significant.
More patients undergoing cardiac valve operations than
patients undergoing CABG were given retrograde car-
dioplegia (64% vs 38%, P = .0003). A greater percent-
age of patients undergoing cardiac valve operations
than those undergoing CABG had left ventricular vent-
ing (99% vs 88%, P = .008). For 99% of patients
undergoing CABG and 85% of patients undergoing
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Table I. Exclusion criteria
CABG—glucose study
Age <35 y
Pregnancy or lactation
Myocardial infarction within 30 d
Valvular heart disease requiring a concomitant operation
Insulin-dependent diabetes mellitus
Inability to perform neurobehavioral testing
Does not speak English
Alzheimer, Parkinson, or Huntington disease
Illiterate
Preoperative dementia
Major depression within 5 y
Alcohol or drug abuse
Renal (creatinine >2 md/dL) or hepatic (AST or ALT >150% 
of upper limit of normal) failure
Received investigational drug within 30 d
Cardiac valve operations—nimodipine study
Age <21 y
Receiving calcium channel blocker drugs preoperatively
Pregnancy
NYHA class IV heart failure
Transmural myocardial infarction within 30 d
Left ventricular ejection fraction <35%
Inability to perform neurobehavioral testing
Does not speak English
Alzheimer, Parkinson, or Huntington disease
Illiterate
Preoperative dementia
Major depression within 5 y
Alcohol or drug abuse
Renal (creatinine >2 mg/dL) or hepatic (AST or ALT >150% of
upper limit of normal) failure
AST, Aspartate aminotransferase; ALT, alanine aminotransferase; NYHA, New
York Heart Association.
cardiac valve operations, venting was accomplished by
using a catheter placed through the right superior pul-
monary vein. The remaining patients were vented
through the left ventricular apex (CABG, 0.5%; cardiac
valve operations, 12.5%) or through an aortic cannula
(CABG, 0.5%; cardiac valve operations, 12.5%). These
differences were statistically significant (P < .0001). It
is our practice to always vent the aorta before and dur-
ing separation from CPB to remove entrained air after
cardiac valve operations, regardless of the venting tech-
nique used during the surgical repair. Palpation of the
aorta by the surgeon revealed that a significantly
greater number of patients undergoing cardiac valve
operations (n = 11) than patients undergoing CABG 
(n = 5) had severe atherosclerosis of the ascending
aorta (Table III).
There were significantly (P = .0001) more emboli in
the patients undergoing cardiac valve operations (medi-
an, 479; geometric mean, 412) than in the patients
undergoing CABG (median, 105; geometric mean, 104;
Fig 1). Inspection of the data confirmed that the total
number of emboli appeared to be log-normally distrib-
uted, and therefore we report geometric means and
medians rather than arithmetic means. At certain times
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Table II. Preoperative demographic and medical characteristics
Parameter Group Mean ± SD (range) or % P value
No. of subjects CABG 193
CVO 74
Female sex CABG 18% <.0001
CVO 56%
Age (y) CABG 61 ± 10 (37-84) .1
CVO 59 ± 12 (21-84)
Weight (kg) CABG 84 ± 18 (41-173) <.0001
CVO 72 ± 17 (45-114)
History of TIA CABG 6% .0035
CVO 16%
History of cerebral infarction CABG 4% .36
CVO 8%
History of cerebral hemorrhage CABG 0% .075
CVO 3%
History of atrial fibrillation CABG 5% <.0001
CVO 33%
Coronary artery disease CABG 100% <.0001
CVO 29%
Peripheral vascular disease CABG 14% .028
CVO 4%
Valvular heart disease CABG 3% <.0001
CVO 100%
History of CHF CABG 4% <.0001
CVO 37%
History of MI CABG 61% <.0001
CVO 14%
Previous cardiac operation CABG 9% .0042
CVO 23%
Diabetes mellitus* CABG 2% .0002
CVO 15%
Hypertension CABG 57% .0010
CVO 34%
Hyperlipidemia CABG 63% <.0001
CVO 30%
CVO, Cardiac valve operation; MI, myocardial infarction.
P values are reported for the t test or exact χ2 test, as appropriate.
*Note that insulin-dependent diabetes was an exclusion criterion for the CABG study but not the cardiac valve operations study.
Table III. Palpation of the thoracic aorta by the 
surgeon 
CABG patients CVO patients
(n = 193) (n = 73) P value*
Normal (%) 85 71
Plaques in innominate 12 11
artery (%) .0012
Minor plaques of ascending 1 3
aorta (%)
Severe plaques of ascending 3 15
aorta (%)
The 4 categories were mutually exclusive, and the worst palpable lesion was
coded in every case. CVO, Cardiac valve operation.
*Exact χ2 test.
during operations, there were significant differences
between the patients undergoing cardiac valve opera-
tions and those undergoing CABG in the number of
emboli (Table IV). Specifically, although there were no
differences between patients undergoing CABG and car-
diac valve operations in the number of emboli recorded
during aortic cannulation, there were significantly more
emboli in the patients undergoing cardiac valve opera-
tions than in the patients undergoing CABG after
removal of the left ventricular vent, separation from
CPB, and removal of the aortic cannula. All these latter
events occurred after cardiac chambers were opened for
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Fig 1. Box plots of the total numbers of emboli counted during either CABG (n = 122 patients) or cardiac valve
operations (n = 34 patients). Note that the data are plotted on a logarithmic scale. Bars denote the median, and shad-
ed boxes include the 25th to 75th percentiles. Whiskers at each end of the shaded boxes provide the 5th and 95th
percentiles of the data. There were significantly (P = .0001) more emboli in patients undergoing cardiac valve oper-
ations (geometric mean, 432 emboli) than in patients undergoing CABG (geometric mean, 111 emboli).
Table IV. Number of emboli occurring within 2 minutes of defined surgical maneuvers
Percentiles
Event Treatment N (10th-25th, median, 75th-90th) P value*
Aortic cannulation CABG 145 (0-0, 2, 5-10) .99
CVO 34 (0-0, 2, 6-20)
Initiation of CPB CABG 144 (0-0, 1, 4-13) .2
CVO 37 (0-0, 0, 2-5)
Removal of LV vent CABG 115 (0-0, 0, 2-9) .0004
CVO 29 (0-0, 6, 31-82)
Cessation of CPB CABG 141 (0-0, 0, 0-7) <.0001
CVO 32 (0-1, 5.5, 26.5-88)
Removal of aortic cannula CABG 141 (0-0, 0, 0-2) .0002
CVO 35 (0-0, 2, 9-22)
The number of subjects varied at different time epochs, depending on our ability to obtain a satisfactory Doppler signal from the left carotid artery. CVO, Cardiac
valve operation; LV, left ventricular.
*Kolmogorov-Smirnov test.
cardiac valve operations. There was no association
between the total number of emboli and age (P = .9).
There were no significant differences between
patients undergoing cardiac valve operations and those
undergoing CABG in their baseline neurobehavioral
scores (Table V). There was a significant effect of time
on the neurobehavioral performance of both groups of
patients. On most tests, the patients demonstrated a sig-
nificant decline in their performance when comparing
the baseline measurement and the measurement record-
ed at 5 to 7 days (Fig 2). There were no significant dif-
ferences between the patients undergoing cardiac valve
operations and those undergoing CABG in their per-
formance preoperatively or postoperatively on our neu-
robehavioral test battery (Fig 2), even after covariate
adjustments. When patients were divided into those
either 60 years of age or older or those less than 60
years of age (60 years was chosen because it was the
mean value of our 2 groups), the older patients scored
significantly worse overall on the tests of Nonverbal
Memory, Symbol-Digit, Trail Making Form B, and
Finger Tapping (nondominant hand). There were no
differences between patients undergoing CABG or
those undergoing cardiac valve operations in the inci-
dence of neurobehavioral deficits (≥20% declines in
performance on a neurobehavioral test) at any of the
postoperative examination times (Table VI). Moreover,
the distribution of deficits was strikingly similar after
the 2 types of cardiac operations.
Extent of proximal aortic disease, as assessed by pal-
pation (see Table III for categories and distribution)
had no significant influence on postoperative neurobe-
havioral performance as assessed either by raw neu-
robehavioral test scores or the incidence of deficits.
Increasing numbers of carotid emboli were signifi-
cantly associated (P = .003) with adverse postoperative
performance on the Letter Cancellation test. There was
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Table V. Baseline group means and SDs for all neurobehavioral tests
Neurobehavioral test Treatment Mean ± SD P value*
Letter Cancellation time (s) CABG 136.0 ± 37.2 .82
CVO 135.0 ± 43.0
Grooved Pegboard, dominant hand (s) CABG 93.4 ± 31.3 .97
CVO 93.3 ± 37.1
Grooved Pegboard, nondominant hand (s) CABG 101.0 ± 29.0 .81
CVO 102.4 ± 45.1
Nonverbal Memory (s) CABG 15.9 ± 2.5 .45
CVO 15.6 ± 3.0
Rey Auditory Verbal Memory Test (No. correct per 105) CABG 46 ± 13 .21
CVO 49 ± 13
Digit Symbol Test (s) CABG 214.0 ± 52.0 .86
CVO 212.6 ± 58.5
Trail Making Form A (s) CABG 63.5 ± 23.6 .35
CVO 66.9 ± 27.8
Trail Making Form B (s) CABG 147.0 ± 68.4 .49
CVO 153.6 ± 73.2
Finger Tapping, dominant hand (No. of taps/10 s) CABG 31.8 ± 8.0 .054
CVO 29.4 ± 9.0
Finger Tapping, nondominant hand (No. of taps/10 s) CABG 28.8 ± 6.8 .068
CVO 26.8 ± 7.9
Visual Reaction Time (s) CABG 1.6 ± 0.9 .54
CVO 1.7 ± 1.0
CVO, Cardiac valve operation.
*t test.
Table VI. Incidence of neurobehavioral deficits
No. of deficits* 
Examination per patient CABG† CVO† P value
5-7 d 0 20% 17% .80
1 19% 17%
2 19% 17%
≥3 43% 50%
1 mo 0 50% 52% .96
1 28% 29%
2 13% 10%
≥3 9% 9%
6 mo 0 51% 44% .46
1 30% 27%
2 12% 13%
≥3 8% 15%
CVO, Cardiac valve operation.
*Deficit is defined as a decrement of 20% or more from the patient’s baseline
score on any neurobehavioral test.
†Total percentage may not be 100 because of rounding.
Table VII. Results on the NIH Stroke Scale
Neurologic measure Date of examination Change from baseline CABG (n) CVO (n) P value
Best gaze 5-7 d Declined 1 0 1.00
No change 142 57
Improved 0 0
1 mo Declined 0 2 1.00
No change 153 58
Improved 0 0
6 mo Declined 0 0 1.00
No change 122 49
Improved 0 0
Best visual 5-7 d Declined 1 0 1.00
No change 142 57
Improved 0 0
1 mo Declined 0 2 .08
No change 153 57
Improved 0 0
6 mo Declined 0 1 .08
No change 122 48
Improved 0 1
Facial palsy 5-7 d Declined 1 0 1.00
No change 144 57
Improved 0 0
1 mo Declined 2 1 1.00
No change 150 58
Improved 2 0
6 mo Declined 3 0 .51
No change 119 48
Improved 1 2
Level of Consciousness 5-7 d Declined 0 0 1.00
(obeys commands) No change 145 57
Improved 0 0
1 mo Declined 0 0 1.00
No change 153 59
Improved 0 0
6 mo Declined 0 0 1.00
No change 123 50
Improved 0 0
Level of Consciousness 5-7 d Declined 0 0 1.00
(response to questions) No change 144 57
Improved 1 0
1 mo Declined 1 0 .71
No change 150 59
Improved 2 0
6 mo Declined 0 0 .59
No change 121 50
Improved 2 0
Best motor response (arm) 5-7 d Declined 2 0 .23
No change 143 56
Improved 0 1
1 mo Declined 0 1 .28
No change 154 58
Improved 0 0
6 mo Declined 0 0 .08
No change 122 48
Improved 0 2
Other arm (for vertebrobasilar 5-7 d Declined 0 2 .09
stroke) No change 130 54
Improved 1 0
1 mo Declined 7 0 .10
No change 123 59
Improved 0 0
6 mo Declined 0 0 1.00 
No change 108 46
Improved 1 0
P values are presented for exact χ2 comparisons between patients undergoing CABG and cardiac valve operation. CVO, Cardiac valve operation, NIH, National
Institutes of Health.
no evidence for a significant difference between patients
undergoing CABG and those undergoing cardiac valve
operations in the association between increasing num-
bers of carotid emboli and worsening performance on
this test (P = .85). There were no overall associations
between increasing numbers of emboli and neurobehav-
ioral test performance, and there were no other neu-
robehavioral tests that demonstrated associations with
emboli that differed significantly between patients
undergoing cardiac valve operations and those undergo-
ing CABG. There were no overall associations between
increasing numbers of carotid emboli and the number of
Fig 2. Percentage change in neurobehavioral test scores achieved by patients undergoing either cardiac valve oper-
ations (filled boxes) or CABG (open boxes). Bars denote the median, and boxes include the 25th to 75th percentiles.
Whiskers at each end of the shaded boxes provide the 5th and 95th percentiles of the data. There were no signifi-
cant differences at any time comparing cardiac valve operations and CABG. For each test, a decline in performance
is indicated as either a percentage increase (+) or a percentage decrease (–) relative to this baseline score. Baseln,
Baseline. *P < .01 compared with the baseline (visit 1) value; †P < .01 compared with the value on day 5 to 7 (visit
2).
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neurobehavioral deficits that a patient might demon-
strate during any one of the 3 postoperative examina-
tions. Moreover, there were no significant interactions
suggesting that emboli might have differing conse-
quences when comparing patients undergoing cardiac
valve operations with patients undergoing CABG.
Results of examinations using the National Institutes
of Health (NIH) Stroke Scale are provided in Table VII.
There were no significant differences between patients
undergoing CABG and those undergoing cardiac valve
operations detected by using the NIH Stroke Scale.
Frank strokes, TIAs, and deaths are presented in Table
VIII. After CABG operations, 4 of the 5 strokes
appeared in the first postoperative neurologic examina-
tion in the intensive care unit. Two of these patients died
subsequently of medical complications on postoperative
days 20 and 161, respectively. One additional patient
had a stroke after being transferred from the intensive
care unit but before hospital discharge. One patient
undergoing cardiac valve operations had a stroke after
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Fig 2. Cont’d.
discharge from the hospital. There were no other signif-
icant differences between the patients undergoing
CABG and those undergoing cardiac valve operations
on their neurologic or neuro-ophthalmologic examina-
tions. No patients had new TIAs. Seven deaths in the
CABG group occurred a median of 43 days after opera-
tions (range, 12-161 days). The single cardiac valve
operation death occurred on postoperative day 2.
Discussion
We and others have previously shown that cardiac sur-
gical patients commonly experience neuropsychologi-
cal deficits, usually defined by declines in one or more
tests of a given amount (often defined as at least 20% or
1 SD from a baseline measurement) and may be more
likely to do so than patients undergoing other types of
operations.6-8 The present study indicates that not only
do cardiac surgical patients have a risk of neurobehav-
ioral deficits but the typical patient can expect an early
postoperative decline in performance, irrespective of
whether the typical patient’s performance may reach the
limiting definition for a deficit.
It is also notable that patients undergoing cardiac valve
operations and those undergoing CABG demonstrated
significant differences between their scores at days 5 to 7
and their scores at 1 month but did not demonstrate sig-
nificant differences between their scores at 1 and 6
months. Similarly, Murkin and colleagues9 showed
almost no difference in the incidence of cognitive dys-
function when comparing 2-month and 3-year postopera-
tive assessments. These results suggest that for purposes
of neurobehavioral assessment, clinical neuroprotection
trials can be limited to a 1-month follow-up examination.
In the older age group that typically undergoes CABG,
limiting the duration of follow-up examinations helps to
reduce the possibility that a postoperative decline in neu-
robehavioral performance might be due to an event
occurring after discharge and essentially unrelated to the
surgical procedure. Our results support the recent report
by Müllges and colleagues,10 showing decline in neu-
robehavioral testing 3 days after CABG, with rapid
improvement only a few days thereafter.
In our 2 groups of contemporaneously enrolled
patients undergoing cardiac valve operations and those
undergoing CABG, there were few significant differ-
ences in their neurobehavioral performances over time.
Both groups declined significantly on many test scores
at 5 to 7 days. By the 1-month examination, test scores
were either not significantly different from baseline or
had significantly improved, reflecting a learning effect
or some other factor related to completion of cardiac
operations. Moreover, the distributions of postoperative
neurobehavioral deficits were remarkably similar in the
groups of patients undergoing cardiac valve operations
and those undergoing CABG. These results are similar
to those reported by Townes and colleagues11 in a study
comparing 65 patients undergoing CABG with 25 oth-
ers undergoing intracardiac operations with CPB.
The incidence and number of deficits depends on the
brain area affected, and therefore the number of deficits
a patient demonstrates is not necessarily associated
with the volume or severity of brain injury, just the
location. We recognize that the likelihood of our detect-
ing a decline in postoperative neurobehavioral perfor-
mance likely increases as the battery of neurobehav-
ioral tests increases. However, both patients undergoing
CABG and those undergoing cardiac valve operations
were evaluated with the same battery of neurobehav-
ioral tests. We also observed no significant differences
between patients undergoing cardiac valve operations
and those undergoing CABG in strokes, TIAs, or
deaths. Confidence intervals are inconsistent with a
trend favoring either class of patients but must be inter-
preted with caution given the minimal number of these
adverse outcomes observed in our patients.
There were significantly more emboli in the patients
undergoing cardiac valve operations than in the
patients undergoing CABG. Notably, there were sig-
nificantly more emboli in the time between removal
of the left ventricular vent and termination of CPB in
the patients undergoing cardiac valve operations than
in the patients undergoing CABG. This difference is
consistent with the common observation of intracar-
diac air bubbles on transesophageal echocardiography
(TEE) near the time of termination of CPB in patients
undergoing cardiac valve operations, although not in
patients undergoing CABG. Unfortunately, we are not
able to relate our carotid Doppler findings with TEE
observations. During the course of these 2 studies,
TEE examination gradually became a routine part of
the care of first the patients undergoing cardiac valve
operations and then later the patients undergoing
CABG but was inconsistently performed during the
course of these 2 clinical trials.
There were other important differences between
patients undergoing cardiac valve operations and those
undergoing CABG. The factors previously reported to
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Table VIII. Incidence of strokes, TIAs, and death
CABG CVO 95% CI
(n = 190) (n = 66) for difference P value
Strokes 2.6% 1.5% (–7.0% to 7.7%) .69
TIAs 0% 0% ND ND
Deaths 3.7% 1.5% (–8.4% to 6.7%) .47
CVO, Cardiac valve operation; CI, confidence interval; ND, Not done.
have the greatest effect on the incidence of post-CPB
neurologic dysfunction are increasing age12,13 and
increasing duration of aortic crossclamping and preex-
isting congestive heart failure (CHF).14 Although the
ages of the 2 groups in our study were similar, the
group of patients undergoing cardiac valve operations
had both a higher incidence of preexisting CHF and
longer aortic crossclamping times. A greater fraction of
patients undergoing cardiac valve operations had
severe atherosclerosis of the ascending aorta by palpa-
tion. We were unable to demonstrate an association
between worsening aortic atherosclerosis and adverse
neurobehavioral outcomes. We recognize that palpa-
tion will not detect many patients with severe aortic
atherosclerosis that might easily be detected by using
epiaortic scanning techniques.15,16 Despite these differ-
ences, the groups of patients undergoing cardiac valve
operations and CABG had similar neurologic out-
comes. This might suggest that cognitive dysfunction
has a differing association with atherosclerosis and
emboli in the 2 groups. Alternatively, these results
could mean that both groups have a similar exposure to
some form of threshold injury (eg, some minimal dura-
tion of CPB or some minimal number of cerebral
emboli). Finally, these results are also consistent with
there being a weak or absent relationship between com-
mon carotid embolic signals and long-term outcome.
Our data also found limited differences between
patients undergoing CABG and those undergoing car-
diac valve operations in the effect that increasing age
had on their neurobehavioral scores.
The similar outcomes despite greater numbers of
emboli in the patients undergoing cardiac valve opera-
tions is also consistent with the idea that some of the
additional emboli in the patients undergoing cardiac
valve operations consist of air rather than the atheroma-
tous material that would be expected to be more preva-
lent in the patients undergoing CABG. Alternatively,
patients undergoing CABG have fewer emboli, but
these emboli are more likely to be particulate. The par-
ticulate emboli may cause more brain injury than
gaseous emboli, thus equalizing the neurobehavioral
results between the 2 groups. We recognize that our
patients undergoing cardiac valve operations appeared
to have a greater incidence of severe aortic atheroscle-
rosis than did our patients undergoing CABG. Although
we were unable to demonstrate an association in this
data set, we recognize that severe aortic disease is a risk
factor for adverse neurobehavioral outcomes.16 In pre-
vious studies of a much larger data set, we have
observed associations between emboli and short-term
neurobehavioral outcome.16,17 We found only limited
association between neurobehavioral outcomes and the
number of emboli we counted in the common carotid
artery. However, our observations suggest that emboli
counts may have no prognostic significance for longer
term outcomes in patients undergoing either CABG or
cardiac valve operations.
For many years, it was believed that patients under-
going cardiac valve operations were at higher risk for
neurologic and neurobehavioral deficits when com-
pared with patients undergoing CABG. During the
1980s, Townes and colleagues11 reported that patients
undergoing either CABG or open-chamber procedures
with CPB had similar neurobehavioral outcomes. More
recently, Kuroda and colleagues18 reported that patients
undergoing CABG had a greater incidence of postop-
erative deficits, although the patients undergoing
CABG were on average 8 years older. We have now
shown in 2 groups of similar ages an equal risk of post-
operative neurobehavioral dysfunction. The pathophys-
iologic cause of this dysfunction is unclear. Micro-
embolic load has been shown to be important in
patients undergoing CABG as a cause of post-CPB
neurologic dysfunction.17,19 Measures that minimize
the number of microemboli, especially particulate
microemboli, are associated with improved neurobe-
havioral outcome.16 The role of gaseous microemboli,
as well as the effect of preexisting CHF and the dura-
tion of aortic crossclamping in patients undergoing car-
diac valve operations, remains unclear.
Our study has clear limitations, and our results
should be interpreted cautiously. Our patients were
enrolled in 2 separate clinical trials with slightly differ-
ent exclusion criteria. Our exclusion criteria may have
eliminated risk factors that, if included, might have
resulted in significant outcome differences between the
2 groups. Insulin-dependent diabetic subjects were
excluded from the CABG study, disproportionately
reducing the number of female subjects who were
enrolled. Patients with severe heart failure were exclud-
ed from the cardiac valve operations study. All patients
had to consent to undergo repeated neurobehavioral
assessments, and it is unclear whether the outcomes of
these consenting patients might differ from those who
refused to participate. All patients underwent an opi-
oid-based general anesthetic. This was typical practice
at the time. Now anesthetics that support early extuba-
tion are more common, and it is unclear whether choice
of general anesthetic might influence neurobehavioral
outcomes. We have shown, subsequent to this study,
that return of shed blood is associated with lipid
microembolization to the brain.20 Unfortunately, we
did not measure shed blood return in these patients and
thus could not determine whether this might differ
between patients undergoing cardiac valve operations
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 1
Neville et al 135
and those undergoing CABG. We counted emboli in the
left common carotid artery, and it is clear that some of
these emboli will not be directed to the brain. The frac-
tion of common carotid artery emboli that enter the
internal carotid artery may differ between patients
undergoing cardiac valve operations and those under-
going CABG. We recognize that the number of emboli
is almost certainly less important than the brain loca-
tion where the emboli lodge and whether the emboli are
particulate or gaseous. Finally, the total number of
patients we studied is relatively small compared with
the several hundred thousand adults who undergo CPB
each year in North America.
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